IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$200M
AUM Growth
-$40.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
142
New
Increased
Reduced
Closed

Top Buys

1
+$16.7M
2
+$13.6M
3
+$9.11M
4
SAGE
Sage Therapeutics
SAGE
+$6.18M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.32M

Top Sells

1
+$12.7M
2
+$11.7M
3
+$11.3M
4
UTHR icon
United Therapeutics
UTHR
+$9.43M
5
CLDX icon
Celldex Therapeutics
CLDX
+$6.2M

Sector Composition

1 Healthcare 98.33%
2 Consumer Staples 0%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
– –
-4,756
102
– –
-40,000
103
– –
0
104
– –
-180
105
– –
-74
106
– –
0
107
– –
-49,372
108
– –
-3,500
109
– –
-29
110
– –
-31,694
111
– –
-21,192
112
– –
0
113
– –
-298
114
– –
-61,433
115
– –
-14,770
116
– –
0
117
– –
-53,703
118
– –
-38,600
119
– –
-5,953
120
– –
-26,831
121
– –
-225,991
122
– –
-80,000
123
– –
0
124
– –
0
125
– –
-40,000
2 3 4
5
6